drugset / Trial / NCT00136981

Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone.

NCT00136981

Phase 3 Completed 800 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The Torcetrapib project was terminated on December 2, 2006 due to safety findings. To look at ultrasound images taken in the carotid arteries and to look at various lipids in the blood of people with heterozygous familial hypercholesterolemia

Timeline

Start
2003-12
Primary completion
Completion
2006-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject torcetrapib Small molecule 60 mg Oral
Background Atorvastatin Small molecule 20 mg Oral
Background Atorvastatin Small molecule 80 mg Oral